Dr. Sunandana Chandra
Claim this profileNorthwestern University
Expert in Melanoma
Expert in Skin Cancer
22 reported clinical trials
31 drugs studied
Area of expertise
1Melanoma
Global LeaderStage IV
BRAF positive
Stage III
2Skin Cancer
Global LeaderStage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Sunandana Chandra is currently running
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting1 award Phase 1 & 210 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Sunandana Chandra
Clinical Trial Related3 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Sunandana Chandra has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Avelumab
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
Breakdown of trials Sunandana Chandra has run
Melanoma
Skin Cancer
Cutaneous Melanoma
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sunandana Chandra specialize in?
Sunandana Chandra focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Sunandana Chandra currently recruiting for clinical trials?
Yes, Sunandana Chandra is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Sunandana Chandra has studied deeply?
Yes, Sunandana Chandra has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Sunandana Chandra?
Apply for one of the trials that Sunandana Chandra is conducting.
What is the office address of Sunandana Chandra?
The office of Sunandana Chandra is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.